FDA denies approval for Fentora non-cancer treatment
BOSTON The Food and Drug Administration has denied approval for Cephalon to market Fentora for treating pain not related to cancer, the company announced Monday.
The opioid painkiller is approved for treating breakthrough pain in some cancer patients, but the company applied for FDA approval to market it for treating chronic back pain and neuropathic pain.
Bayer denies takeover rumors
FRANKFURT, Germany Reports of Bayer’s imminent takeover appear greatly exaggerated.
The company’s chief executive officer told a German newspaper that it would not be taken over, amid rumors last week that Pfizer sought to acquire it. But Bayer has a number of drugs in its research pipeline, while many of Pfizer’s blockbuster drugs will soon go off patent, facing competition from generic drug makers.
MyMedSchedule now available to the public
INDIANAPOLIS A service that helps people with organ transplants manage their medication schedules has become available to the public.
MyMedSchedule used to be available only in hospitals, reminding organ transplant recipients to take their medications and helping them avoid errors. People who have received transplants often must take several drugs to avoid rejection of the new organs.
Companies such as Community Health Network and the American Society of Health-System Pharmacists offer similar services.